Are neuropsychological tests useful in screening for the genetic risk of Parkinson's disease?

Parkinsonism and Related Disorders

Volumn 3, Issue 3, 1997, Pages 141-150

  Vieregge, Peter ^a   Heberlein, Ilse ^a   Kömpf, Detlef ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Family studies; Genetics; Neuropsychology; Parkinson's disease

Indexed keywords

AGE; ARTICLE; DIAGNOSTIC VALUE; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN EXPERIMENT; INTELLIGENCE QUOTIENT; MALE; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PERSONALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST;

EID: 0031471507     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(97)00012-6     Document Type: Article

References (69)

1. Poewe W., Gerstenbrand F., Ransmayr G., Plörer S. Premorbid personality of Parkinson patients. J Neural Transm 1983; 19 (Suppl): 215-224.
2. Hubble J.P., Venkatesh R., Hassanein R.E.S., Gray C., Koller W.C. Personality and depression in Parkinson's disease. J Nerv Ment Dis 1993; 181: 657-662.
3. Todes C.J., Lees A.J. The pre-morbid personality of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1985; 48: 97-100.
4. Koller W.C. When does Parkinson's disease begin?. Neurology 1992; 42 (Suppl 4): 27-31.
5. Planté-Bordeneuve V., Taussig D., Thomas F., Ziégler M., Said G. A clinical and genetic study of familial cases of Parkinson's disease. J Neurol Sci 1995; 135: 164-172.
6. Bonifati V., Fabrizio E., Vanacore N., DeMari M., Meco G. Familial Parkinson's disease: A clinical genetic analysis. Can J Neurol Sci 1995; 22: 272-279.
7. Polymeropoulos M., Higgins J.J., Golbe L.I., et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 1996; 274: 1197-1199.
8. 18F)Dopa positron emission tomography studies in an Irish kindred. Neurology 1992; 32: 609-617.
9. 18F-dopa positron emission tomography scanning in a family with familial Lewy body disease. Mov Disord 1994; 9 (Suppl 1): 119.
10. Llerena A., Edman G., Cobaleda J., Benitez J., Schalling D., Bertilsson L. Relationship between personality and debrisoquine hydroxylation capacity. Acta Psychiatr Scand 1993; 87: 23-28.
11. Armstrong M., Daly A.K., Cholerton S., Bateman D.N., Idle J.R. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 1992; 339: 1017-1018.
12. Smith C.A.D., Gough A.C., Leigh P.N., et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992; 339: 1375-1377.
13. Diederich N., Hilger C., Goetz C.G., Keipes M., Hentges F., Vieregge P., Metz H. Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease. Ann Neurol 1996; 40: 463-465.
14. Gibb W.R.G., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752.
15. Dexter D.T., Sian J., Rose S., et al. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol 1994; 35: 38-44.
16. Doty R.L., Deems D.A., Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988; 38: 1237-1244.
17. Caliri A.M., Golbe L.I. Olfactory and personality tests as premorbid screening for Parkinson's disease. Neurology 1992; 42 (Suppl 3): 440.
18. Cools A.R. Role of neostriatal dopaminergic activity in sequencing and selecting behavioral strategies: facilitation of processes involved in selecting the best strategy in a stressful situation. Beav Brain Res 1980; 1: 361-378.
19. 9 circuitries. In: Wolters EC, Scheltens P, eds. Mental dysfunction in Parkinson's disease. Dordrecht: The ICG publications, 1994: 49-67.
20. Schneider J.S., Pope-Colman A. Cognitive deficits precede motor deficits in a slowly progressive model of Parkinsonism in the monkey. Neurodegeneration 1995; 4: 245-255.
21. Alexander G.E., Crutcher M.D., DeLong M.R. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. Progr Brain Res 1990; 85: 119-146.
22. Javoy-Agid F., Agid Y. Is the mesocortical dopaminergic system involved in Parkinson's disease?. Neurology 1980; 30: 1326-1331.
23. Fibiger H.C. The neurobiological substrates of depression in Parkinson's disease: a hypothesis. Can J Neurol Sci 1984; 11: 105-107.
24. Cummings J.L. Depression and Parkinson's disease: a review. Am J Psychiatry 1992; 149: 443-454.
25. Menza M.A., Golbe L.I., Cody R.A., Forman N.E. Dopamine-related personality traits in Parkinson's disease. Neurology 1993; 43: 505-508.
26. Burn D.J., Mark M.H., Playford E.D., et al. Parkinson's disease in twins studied with 18 F-dopa and positron emission tomography. Neurology 1992; 42: 1894-1900.
27. Holthoff V.A., Vieregge P., Kessler J., et al. Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol 1994; 36: 176-182.
28. Calne D.B., Langston J.W., Martin W.R.W., et al. Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease. Nature 1985; 317: 246-248.
29. Stern Y., Tetrud J.W., Martin W.R.W., Kutner S.J., Langston J.W. Cognitive change following MPTP exposure. Neurology 1990; 40: 261-264.
30. Lees A.J., Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983; 106: 257-270.
31. Taylor A.E., Saint-Cyr J.A., Lang A.E. Parkinson's disease: cognitive changes in relation to treatment response. Brain 1987; 110: 35-51.
32. Reid W.G.J., Broe G.A., Hely M.A., et al. The neuropsychology of de novo patients with idiopathic Parkinson's disease: the effects of age of onset. Int J Neuroscience 1989; 48: 205-217.
33. Taylor A.E., Saint-Cyr J.A., Lang A.E. Memory and learning in early Parkinson's disease: evidence for a 'frontal lobe syndrome'. Brain Cogn 1990; 13: 211-232.
34. Cooper J.A., Sagar H.J., Jordan N., Harvey N.S., Sullivan E.V. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991; 114: 2095-2122.
35. Hartikainen P., Helkala E.L., Soininen H., Riekkinen P. Cognitive and memory deficits in untreated Parkinson's disease and amyotrophic lateral sclerosis patients: a comparative study. J Neural Transm P-D Sect 1993; 6: 127-137.
36. Mayeux R., Stern Y., Rosen J., Leventhal J. Depression, intellectual impairment, and Parkinson's disease. Neurology 1981; 31: 645-650.
37. Mayeux R., Stern Y., Cote L., Williams J.B.W. Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology 1984; 34: 642-646.
38. Santamaria J., Tolosa E.S., Valles A., Bayes A., Blesa R., Masana J. Mental depression in untreated Parkinson's disease of recent onset. Adv Neurol 1986; 45: 443-446.
39. Hubble J.P., Cao T., Hassanein R.E.S., Neuberger J.S., Koller W.C. Risk factors for Parkinson's disease. Neurology 1993; 43: 1693-1697.
40. Tsai C.H., Lu C.S., Hua M.S., Lo W.L., Lo S.K. Cognitive dysfunction in early onset parkinsonism. Acta Neurol Scand 1994; 89: 9-14.
41. Dalrymple-Alford J.C., Jamieson C.F., Donaldson I.MacG. Effects of selegiline on cognition in early Parkinson's disease. Clin Neuropharmacol 1995; 57: 360-367.
42. Lauterbach E.C., Duvoisin R.C. Anxiety disorders in familial Parkinsonism. Am J Psychiatry 1991; 148: 274.
43. Lauterbach E.C. The locus ceruleus and anxiety disorders in demented and nondemented familial parkinsonism. Am J Psychiatry 1993; 150: 994.
44. Winokur A., Dugan J., Mendels J., Hurtig H.I. Psychiatric illness in relatives of patients with Parkinson's disease: an expanded survey. Am J Psychiatry 1978; 135: 854-855.
45. Vieregge P. Genetic factors in the etiology of idiopathic Parkinson's disease. J Neural Transm P-D Sect 1994; 8: 1-37.
46. Hellenbrand W., Vieregge P., Robra B.P., et al. Die Ätiologie des Morbus Parkinson: Eine epidemiologische Perspektive mit möglichen Implikationen für die Prävention. Nervenarzt 1993; 64: 770-786.
47. Fearnley J.M., Lees A.J. Aging and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283-2301.
48. Agid Y., Ruberg M., Javoy-Agid F., et al. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?. Adv Neurol 1993; 60: 148-164.
49. Zimmerman T.R., Bhatt M., Calne D.B., Duvoisin R.C. Parkinson's disease in monozygotic twins: a follow-up. Neurology 1991; 41 (Suppl 1): 255.
50. Vieregge P., Schiffke K.A., Friedrich H.J., Müller B., Ludin H.P. Parkinson's disease in twins. Neurology 1992; 42: 1453-1461.
51. Heberlein I., Vieregge F., Friedrich H.-J., Kömpf D. Neuropsychological deficits in middle-aged children of sporadic patients with Parkinson's disease. Mov Disord 1994; 9 (Suppl 1): 29.
52. Wechsler D. Handanweisung zum Hamburg-Wechsler-Intelligenztest für Erwachsene (HAWIE). Bern-Stuttgart-Wien: Hans Huber, 1982.
53. Lezak M. Neuropsychological Assessment, 3nd edn. New York: Oxford University Press, 1995.
54. Benton A.L. & Hamsher K. Multilingual Aphasia Examination. Iowa City: University of Iowa Press, 1976.
55. Levin B.E., Llabre M.M., Weiner W.J. Cognitive impairments associated with early Parkinson's disease. Neurology 1989; 39: 557-561.
56. Newcombe F. Missile Wounds of the Brain: a Study of Psychological Deficits. London: Oxford University Press, 1969.
57. Nelson H.E.A. A modified card sorting test sensitive to frontal lobe defects. Cortex 1976; 12: 313-324.
58. Zerssen D. von & Koeller D.M. Paranoid-Depressivitäts-Skala. Weinheim: Beltz Test, 1976.
59. Zerssen D. von & Koeller D.M. Die Beschwerdenliste. Weinheim: Beltz Test, 1976.
60. Fahrenberg J., Hampel R. & Selg H. Das Freiburger Persönlichkeitsinventar (FPI). Revidierte Fassung und teilweise geänderte Fassung FPI-A1. Handan Weisung. Göttingen-Toronto-Zürich: Verlag für Psychologie Dr. CJ Hogrefe, 1984.
61. Schoppe K.J. Das MLS-Gerät: Ein neuer Testapparat zur Messung feinmotorischer Leistungen. Diagnostica 1980; 20: 43-46.
62. Malapani C., Pillon B., Dubois B., Agid Y. Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine related dysfunction. Neurology 1994; 44: 319-326.
63. Drühe-Wienholt C.M. Leistungen von Parkinsonpatienten im Wisconsin Kartensortiertest in Abhängigkeit von der Testversion (Milner versus Nelson). Zeitschr Neuropsychologie 1993; 4: 27-33.
64. Downes J.J., Sharp H.M., Costall B.M.C., Sagar H.J., Howe J. Alternating fluency in Parkinson's disease. Brain 1993; 116: 887-902.
65. Kieburtz K., McDermott M., Como P., et al. The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Neurology 1994; 44: 1756-1759.
66. Kish S.J., Sannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. New Engl J Med 1988; 318: 876-880.
67. Perry T.L., Bratty P.J.A., Hansen S., Kennedy J., Urquhart N., Dolman C.L. Hereditary mental depression and parkinsonism with taurine deficiency. Arch Neurol 1975; 32: 108-113.
68. Bhatia K.P., Daniel S.E., Marsden CD. Familial parkinsonism with depression: a clinicopathological study. Ann Neurol 1993; 34: 842-847.
69. Rajput A.H., Rozdilsky B., Rajput A. Accuracy of clinical diagnosis in parkinsonism - a prospective study. Can J Neurol Sci 1991; 18: 275-278.